🔎 Trials Near Me

Hem › Migrän › New York

Kliniska studier för Migrän i New York

15 studier för Migrän söker deltagare vid platser i New York.

Städer i New York

Officiell studietext (engelska)

Study of EVO756 in Adults With Migraine

  • Clinosis - Dent Neurologic Instite, Amherst
RekryterarFas 2
Ålder 18 till 64 · Alla kön · Uppdaterad 2 okt. 2026 · NCT07616128

A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine

  • True North Neurology, Port Jefferson Station
RekryterarFas 1
Ålder 6 till 11 · Alla kön · Uppdaterad 28 sep. 2026 · NCT06995729

Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

  • Montefiore Medical Center, The Bronx
RekryterarFas 3
Ålder 6 till 17 · Alla kön · Uppdaterad 28 sep. 2026 · NCT05156398

MMA Embolization for Refractory Chronic Migraine

  • University of Buffalo Medical Center, Buffalo
  • Mount Sinai, New York
  • Stony Brook University Medical Center, Stony Brook
Rekryterar
Ålder 18 till 65 · Alla kön · Uppdaterad 25 sep. 2026 · NCT06735833

A Comparison of Nurtec ODT to Maxalt MLT-ODT in Adult ED Patients With Migraine Headache

  • Maimonides Medical Center, Brooklyn
RekryterarFas 4
Ålder 18 till 65 · Alla kön · Uppdaterad 24 sep. 2026 · NCT06473597

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

  • Dent Neurosciences Research Center, Amherst
  • True North Neurology, Commack
  • New York Neurology Associates, New York
RekryterarFas 3
Ålder 6 till 17 · Alla kön · Uppdaterad 24 sep. 2026 · NCT04743141

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

  • Dent Neurosciences Research Center, Amherst
  • True North Neurology, Commack
  • Northwell Health IRB, Great Neck
  • och 4 fler
RekryterarFas 3
Ålder 6 till 17 · Alla kön · Uppdaterad 24 sep. 2026 · NCT04649242

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

  • Dent Neurologic Institute - Amherst /ID# 270260, Amherst
RekryterarFas 3
Ålder 12 till 17 · Alla kön · Uppdaterad 22 sep. 2026 · NCT06810505

Responding With Evidence and Access for Childhood Headaches

  • Dent Neurological Institute, Amherst
Rekryterar
Ålder 10 till 17 · Alla kön · Uppdaterad 21 sep. 2026 · NCT05889624

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

  • Nuvance Health Institute, Kingston
  • Northwell Health, Manhasset
  • Mt Sinai Icahn School of Medicine, New York
RekryterarFas 4
Ålder 18 till 70 · Alla kön · Uppdaterad 16 sep. 2026 · NCT06972056

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

  • Dent Neurologic Institute - Amherst /ID# 231182, Amherst
  • SUNY Upstate Medical University /ID# 239898, Syracuse
RekryterarFas 3
Ålder 6 till 17 · Alla kön · Uppdaterad 14 sep. 2026 · NCT05125302

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

  • Dent Neuro Institute, Buffalo, Amherst
  • SPRI Clinical Trials, LLC, Brooklyn
  • True North Neurology, Commack
  • och 4 fler
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 20 aug. 2026 · NCT07645924

A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine

  • True North Neurology, Commack
RekryterarFas 3
Ålder 6 till 17 · Alla kön · Uppdaterad 12 juni 2026 · NCT05164172

Bilateral Middle Meningeal Artery Lidocaine Infusion for Chronic Debilitating Migraines

  • Neuroscience Institute at Great Neck, Great Neck
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 22 maj 2026 · NCT07061847

RELAXaHEAD for Headache Patients (Phase III)

  • NYU Langone Health, New York
Rekryterar
Ålder 16 till 80 · Alla kön · Uppdaterad 10 okt. 2025 · NCT06077838

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.